Skip to main content
Premium Trial:

Request an Annual Quote

Bioline EPIK miRNA Panel Assays

Meridian Bioscience subsidiary Bioline has launched panel assay kits for miRNA profiling of cancer samples, biofluids, and stem cells. EPIK miRNA Panel Assays are the result of a collaboration between Singapore firm MiRXES and Bioline. The assays use combinations of miRNA specific reverse transcriptase and hemi-nested real-time PCR primers designed to maximize miRNA detection sensitivity and specificity, as well as SensiSMART with SYBR Green to enable detection of low levels of miRNA and allow discrimination between closely related miRNA sequences.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.